P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEA...

por Zeiser, R., Russo, D., Ram, R., Hashmi, S., Chakraverty, R., Moritz Middeke, J., Giebel, S., Sarkar, R., Gowda, M., Gunes, S., Stefanelli, T., Lee, S. J., Teshima, T., Locatelli, F.
Publicado 2022